This session provided an overview of the draft national plan for pandemic influenza preparedness, recently released by the U.S. Department of Health and Human Services, and identified key challenges for its implementation. Lessons learned from the current influenza vaccine shortage were examined to more broadly inform pandemic preparedness planning. The perspectives and concerns of stakeholder groups involved in preparedness development, including the vaccine industry, state and local public health officials, health care providers, and the public at large, were explored.
Bruce Gellin, MD, MPH, Director, National Vaccine Program Office
With comments from an expert panel:
Anita Barry, MD, MPH , Director, Communicable Disease, Control DivisionBoston Public Health Commission; Kathleen F. Gensheimer, MD, MPH, State Epidemiologist, Maine Department of Health and Human Services; Christine Grant, JD, MBA, Vice President for Public Policy and Government Relations, Aventis Pasteur, Inc.; Roz Lasker, MD, Director, Division of Public Health, The New York Academy of Medicine; David J. Witt, MD, Chief of Infectious Diseases, Kaiser Permanente, San Rafael Medical Center
Slides from the presentation by Dr. Gellin are available for download.
See also the related Background Paper.